PIEZO1 and central nervous system cancer: A high frequency of mutations in IDH1 and Chr1p19q was detected in gliomas with low PIEZO1 expression (Fig. 3A), while mutations in TTN, PTEN and NF1 were significantly enriched in cases with high expression of PIEZO1 (Fig. 3B).